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Objective: To conduct a literature review in search of possible preventable causes for
fetal growth restriction.
Methods: We performed a systematic literature search regarding abnormal vaginal
microflora and fetal growth encompassing the last 27-year (starting from 1986) in
PubMed, Embase, and Cochrane Central to study the evidence that abnormal vaginal
microflora is may be related to diminished fetal growth or small for date birth.
Results: Most of the 14 studies suggested a significant role of vaginal organisms in impaired
fetal growth, unrelated to preterm birth. The neonatal outcome has shown to be largely linked
to the preventable or foreseeable fetal factors, such as genetic abnormalities, but also
ascending intrauterine infections. Our previous work suggested a role of vaginal organisms in
adverse pregnancy outcome, not only preterm birth, but also impaired fetal growth.
Conclusions: There is a need for cohort studies designed to unravel this link between
abnormal microflora and FGR, in order to enable preventive actions to protect these small
babies from severe damage and death by early screening and treatment.1. Introduction
Fetal growth restriction (FGR) is defined as the inability of a
fetus to maintain its expected growth [1]. In spite of the advanced
and sophisticated diagnostic technologies, it remains a major
challenge for obstetricians to understand its pathogenicity in
order to adjust treatment or preventive actions. Indeed, FGR is
associated with significant perinatal morbidity and mortality [2],
an increased risk of neurological impairment in childhood [3,4]
and cardiovascular and metabolic diseases in adults [5]. These
complications are mostly related to the newborns with a birth
weight below the 3rd percentile [6]. Known contributing factors
to the ethiology of FGR are substance abuse, fetal
chromosomal anomalies, hypertension and severe chronic
maternal diseases [7–9]. Also infections with cytomegalovirus,
Toxoplasma gondii (T. gondii), herpes virus and rubella have
been shown to cause detrimental effects on fetal growth [10–12].However, the role of other infectious agents and genital
infections remain controversial and perhaps underestimated.
According to several follow-up studies, there is a strong link
between infectious conditions of the lower genital tract, such as
bacterial vaginosis (BV), aerobic vaginitis (AV) and trichomo-
niasis (TV) and preterm deliveries [13–18]. Among bacterial
infections, Ureaplasma urealyticum (U. urealyticum),
Mycoplasma hominis (M. hominis) and bacterial vaginosis
associated organisms have been linked to an increased risk of
miscarriage, as they are thought to interfere with trophoblast
formation [19,20]. At the same time, little attention is paid to the
possible effect of abnormal genital flora on fetal growth.
2. Materials and methods
We performed a systematic review of the literature about the
correlation between bacterial vaginosis and FGR in order to
provide evidence for the hypothesis that the presence of
abnormal vaginal flora can be responsible for intrauterine growth
restriction.
We performed a literature search encompassing the last 27-year
(starting from 1986) in PubMed, Embase, and Cochrane Central.
Keywords and MeSH terms were combined to generate lists of
studies: bacterial vaginosis, abnormal microflora, vaginitis,n open access article under the CC BY-NC-ND
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tion, and birth weight. Papers containing original data were
includedwithout language restriction. The outcomemeasureswere
diminished fetal growth or small for date birth weight.
3. Results
The literature search identified 14 eligible studies (Table 1).
Investigators of the John Hopkins study found colonization with
Chlamydia trachomatis (C. trachomatis) (OR 2.4, 90% CI 1.32–Table 1
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associated with a significant increased risk for FGR (OR 1.79,
95% CI 1.27–2.52). Carey et al. analyzed cultures from the
vagina and cervix of 4934 pregnant women and found that
birthweight of newborns from mothers colonized with
U. urealyticum was significantly lower than those who were not
(3 276 g vs. 3 325 g, P < 0.01) [24]. But after adjustment for
ethnicity, parity, smoking and age this difference in the mean
birth weight was no longer significant. Also Donders et al. [16]
found the correlation between abnormal vaginal microflora and
reduced fetal head circumference together with diminished birth
weight in the study group (P < 0.0001), but in his study,
specific BV microflora alone was not associated with FGR. In
2006 three studies were published simultaneously regarding
abnormalities of vaginal microflora and newborn weight.
Thorsen et al. [25] followed women from 24 weeks of gestation
until delivery in a population-based prospective study and
found that BV was associated with small for gestational age
(SGA) babies in nulliparous, but not multiparous women. In a
study of 3 262 singleton pregnancies included before 20 weeks of
gestation Svare et al. [27] found that mean birthweight was
significantly lower in infants of women with BV than in infants
of women without BV (3 408 g vs. 3 511 g, P < 0.01), where
BV was only marginally associated with preterm delivery (OR
1.5, 95% CI 1.0–2.1). Also after multivariate analyses adjusting
for previous miscarriage, smoking, gestational diabetes and
fetal death showed this association between BV and low
birthweight remained significant (OR 2.7, 95% CI 1.4–5.1).
According to Vogel et al. [26] pregnant women with BV had a
twofold increased risk of SGA newborns when they were
colonized with U. urealyticum, leading to the suggestion that
U. urealyticum may intensify the risk of lower birthweight in
women with BV. Kalinka et al. [34] studying Chlamydia in
pregnancy, demonstrated significant differences in neonatal
weight between groups with and without BV. BV was
diagnosed in 28.1%, grade II microflora in 71 (36.2%) of the
women. As lactobacilli grade II flora [16] often harbours non
BV flora like Escherichia coli (E. coli) and enterococci, the
possibility of ascending infection should be considered in some
cases. An animal study demonstrated that the fetal and placental
weight were significantly lower in E. coli infected rats than in
the noninfected controls [41].
According to results of Vedmedovska et al. genital infections
including BV during the current pregnancy were more frequent
in the FGR group than in the control group [28]. Furthermore,
women with genital infections had four times more frequently
Doppler flow abnormalities of the uterine and fetal vessels
than control women as a possible explanation for the FGR
(P = 0.02) [29].
In 4 of 14 papers the authors did not find significant differences
of the neonatal birth weight in women with or without BV [30–33].
Recently, a group of Latvian researches studying the effect of
Vitamin C on vaginal microflora and the outcome of pregnancy,
demonstrated lower birth weights in women with AV (3 497 g
vs. 3 576 g, P = 0.045) and in the group harbouring mixed BV
and AV (3 430 g vs. 3 576 g, P = 0.02) compared to the normal
vaginal microflora group.
4. Discussion
Although previous reports demonstrate that about 5%–10 %
of the cases with FGR may be attributable to viral or protozoaninfections in utero, its possible relation to reproductive tract in-
fections was not mentioned [7]. According to results of our
literature search, there is also evidence that abnormal vaginal
microflora may be involved in the causation of FGR.
Ascending genital infections can install low grade intrauterine
infection and inflammation, selectively damage the invasive
trophoblast cells, disturb placental invasion and result in later
placental dysfunction, thereby affecting intrauterine fetal growth
potential [35]. The damage of trophoblast cells may be mediated
through elevated levels of the proinflammatory cytokine IL-1b
and the inhibition of other chemokines. Marconi et al. found
that the presence of C. trachomatis endocervicitis is associated
with increased cervicovaginal IL-1b, IL-6 and IL-8 levels in
women with concomitant BV, but not in those with normal flora
[36]. She and others have found that IL-1b is increased in BV, but
not IL-6 and IL-8, and typically, no leukocytosis or other signs of
inflammatory response are seen in the vaginal fluid of women
with BV [36–39]. Of note, also in women with AV, IL1b is
produced in large quantities [36,37].
As altered chemokine production by the trophoblast prevents
migration of macrophages into the maternal-fetal interface [35],
this altered innate immune responses may have an impact on
trophoblast function later in pregnancy and contribute to the
pathology, such as first trimester miscarriages [40] and deprived
fetal growth. It seems plausible that BV and abnormal vaginal
flora have similar effects on the innate immunity of trophoblast
in the first trimester and subsequent alterations of spiral artery
remodeling during ongoing pregnancy.
Furthermore the association of reproductive tract infections
with abnormal Doppler flow pattern types, may predispose the
patient to placental abruption, a major cause of the increased
perinatal mortality in FGR pregnancies.
Besides above discussed alterations of trophoblast prolifera-
tion, a possible explanation of infection related FGR may also be
transplacental transfer of virulent bacteria, such as E. coli [41], or
specific BV associated bacteria directly to the developing fetus,
causing low grade congenital bacterial infection in fetal organs.
The FGR may also be the result of infection-induced placental
changes, such as thrombosis, necrosis and destruction of
placental villi [29,42].
Firm conclusions from our literature review are hampered by
the heterogeneous gestational age at entry of most studies,
different definitions of main outcome, and varying diagnostic
methods to define altered microflora. Furthermore, the majority
of previous trials were designed to evaluate the effect of BV on
premature delivery, missing potentially important association
with fetal growth deficiencies. Hence we would advocate that
further studies of abnormal vaginal flora in pregnancy would
aim to resolve the impact of vaginal and cervical flora alterations
on fetal growth potential, using standardized and well defined
criteria for both diagnosis of AVF (abnormal vaginal flora) and
outcome (SGA newborns).
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